Skip to content

NEXM NEXM Deferred Valuation Allowance

Deferred Valuation Allowance at other companies

Envoy Medical logo
Envoy MedicalCOCH
$654K+2.5%
Cineverse Corp. logo
Cineverse Corp.CNVS
$31.36M+0.7%
Heartland Express logo
Heartland ExpressHTLD
$0
Ametek logo
AmetekAME
$33.55M+57.5%
U.S. Bancorp logo
U.S. BancorpUSB
$432M+11.1%
Flexible Solutions International logo
Flexible Solutions InternationalFSI
$2.92K-98.5%

Other financials

Income statement

See full
Net income-$10.6M+30.2%
EPS (diluted)$0.30-77.9%

Balance sheet

See full
Cash & equivalents$25.9M-42.6%
Total debt$1.3M
Total equity$71.7M+39.0%
Total assets$81.1M+27.1%

Cash flow

See full
Operating cash flow-$12.2M-93.9%
CapEx$768.5K+1,436%
Free cash flow-$13.0M-104%

Valuation

See full
Market cap$83.95M-25.5%
Enterprise value$59.36M

Returns & leverage

See full
Return on equity-88.4%-30.3pp
Debt / equity
Current ratio7.7×+1.3×

Where this comes from

Reported directly by NEXM in its filing.

Tagged under the XBRL concept NEXM:DeferredValuationAllowance.

The official record: NEXM’s 10-K/A, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about NEXM's deferred valuation allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NEXM's deferred valuation allowance?
NEXM (NEXM) reported deferred valuation allowance of -$32.8M in Q4 2025.
What does deferred valuation allowance mean?
This is a contra-asset account used to reduce the carrying value of deferred tax assets when it is more likely than not that some portion will not be realized. A high or increasing allowance suggests management's uncertainty regarding the company's ability to generate sufficient future taxable income.